Abiopharma

Director ORBIMED ADVISORS LLC 🟢 acquired 36.9M shares (4 derivative) of Shattuck Labs, Inc. (STTK) at $1.08 ($25.5M) Transaction Date: Aug 25, 2025 | Filing ID: 000840

Director Ashiya Mona 🟢 acquired 36.9M shares (4 derivative) of Shattuck Labs, Inc. (STTK) at $1.08 ($25.5M) Transaction Date: Aug 25, 2025 | Filing ID: 000839

New Form 3 - Shattuck Labs, Inc. Filed: 2025-09-02 AccNo: 0000947871-25-000838 Size: 6 KB

RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Dizon Romeo R 🟢 acquired 625 shares of IRIDEX CORP (IRIX) at $1.34 Transaction Date: Sep 02, 2025 | Filing ID: 112648

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock

CLINUVEL Date of Annual General Meeting

Chapman Rowan E 🟡 adjusted position in 187 shares of Natera, Inc. (NTRA) at $166.99 Transaction Date: Jun 27, 2025 | Filing ID: 023477

Pulik Richard 🔴 sold 2.3K shares of Roivant Sciences Ltd. (ROIV) at $11.94 Transaction Date: Aug 28, 2025 | Filing ID: 033687

NASDAQ traded attribute type Security_Name was changed. Previous value: Connect Biopharma Holdings Limited - American Depositary Shares. New value: Connect Biopharma Holdings Limited - Ordinary Shares.

New Form S-3MEF - Mineralys Therapeutics, Inc. Filed: 2025-09-02 AccNo: 0001933414-25-000112 Size: 278 KB

Jonasson Zachariah 🔴 sold 8.3K shares of Absci Corp (ABSI) at $2.39 Transaction Date: Aug 31, 2025 | Filing ID: 000043